Galderma

brand-profile-thumb

Company Headquarters

Galderma SA, Zählerweg 10, 6300 Zug, Switzerland

Driving Directions

Brand Description

Galderma is the leading company solely dedicated to skin and advancing the future of dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.

Brands

BRANDS
MARKETS
    No Brand Found for this Company.

Key Personnel

NAME
JOB TITLE
  • Dr. Flemming Ørnskov
    CEO
  • Lisa Morris
    Vice President and General Manager of US Consumer Business
  • Karen Ling
    Chief Human Resources Officer, M&A and Integrations

Yearly results

Sales: 1.1 Billion

Sales: $1.1 billion

Comments: Galderma is a privately-held company and the world’s largest independent dermatology company, with annual sales of $3.7 billion. It is present in approximately 100 countries. Galderma’s portfolio includes brands and services across aesthetics, consumer care and prescription medicine.

The company recently raised about $1 billion through a private placement of shares after plans for a stock market listing were delayed. The newly-issued shares are being divvied up between shareholders and management and undisclosed external investors per officials. Proceeds will be used to buttress its balance sheet and accelerate growth.

Galderma had a strong presence at the 25th World Congress of Dermatology (WCD) in Singapore last month. It presented almost 60 abstracts and convened separate symposium from Galderma’s Sensitive Skincare Faculty in collaboration with George Washington University.

Galderma also hosted an acne symposium at WCD featuring new phase IV study data investigating the efficacy and safety of trifarotene cream on acne and the risk of formation of acne scars.


ReSurface Skin Polish delivers the power of dual-action exfoliation through volcanic minerals and glycolic acid in a non-irritating, hydrating formula. The product is clinically proven to help improve tactile roughness and skin dullness in a week.

Sales: 1.3 Billion

Sales: $1.3 billion

Galderma is a privately-held company and the world’s largest independent dermatology company, present in approximately 100 countries. Its portfolio includes sophisticated brands and services across aesthetics, consumer care and prescription medicine.

In February 2022, Galderma and Taro Pharmaceutical Industries Ltd. signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company. The agreement includes Alchemee’s business and assets around the world, including the Proactiv brand.

Also making news for Galderma in 2022 is its leading mass market brand Cetaphil. The sensitive skin care leader has revamped its skin care products with “new and improved” formulas featuring a dermatologist-backed blend of niacinamide (vitamin B3), panthenol (vitamin B5) and hydrating glycerin to improve skin’s overall resilience. The brand debuted its Sensitive Skin Awareness Month this past March, a digitally focused marketing campaign that arms consumers with science-backed guidance on how to identify, care for, and treat sensitive skin of all kinds.

Cetaphil revamped its skin care products with “new and improved” formulas featuring a dermatologist-backed blend of niacinamide, panthenol and hydrating glycerin to improve skin’s overall resilience.

 

Related Content